PDL BioPharma, Inc. ROE

ROE of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROE growth rates and interactive chart. ROE is expressed as a percentage and can be calculated for any company if net income and equity are both positive numbers. Net income is calculated before dividends paid to common shareholders and after dividends to preferred shareholders and interest to lenders. A company with average equity of $10 million and earnings of $2 milion will have a ROE of 20%.

Highlights and Quick Summary

  • Annual ROE for 2019 was -10.64% (a 21.74% increase from previous year)
  • Annual ROE for 2018 was -8.74% (a -163.2% decrease from previous year)
  • Annual ROE for 2017 was 13.83% (a 57.88% increase from previous year)
  • Twelve month ROE ending June 29, 2020 was -28.44% (a 62.98% increase compared to previous quarter)
  • Twelve month trailing ROE decreased by -25954.55% year-over-year
Trailing ROE for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-28.44% -17.45% -10.64% 0.11%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROE of PDL BioPharma, Inc.

Most recent ROEof PDLI including historical data for past 10 years.

Interactive Chart of ROE of PDL BioPharma, Inc.

PDL BioPharma, Inc. ROE for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 -10.64%
2018 -8.74%
2017 13.83%
2016 8.76%
2015 57.56%
2014 112.29%
2013 1166.18%
2012 -155.41%
2011 -75.46%
2010 -24.83%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.